Navigation Links
New Federal Training Grant to Teach Doctors/Scientists Immunology
Date:8/20/2009

The Schneider Children's Hospital (SCH) campus of The Feinstein Institute for Medical Research has been awarded a prestigious $795,000 federal grant to hire and train the next generation of immunologists who will investigate diseases of the immune system to provide cutting-edge care to patients.

Manhasset, NY (Vocus) August 20, 2009 -- The Schneider Children's Hospital (SCH) campus of The Feinstein Institute for Medical Research has been awarded a prestigious $795,000 federal grant to hire and train the next generation of immunologists who will investigate diseases of the immune system to provide cutting-edge care to patients.

The new federal "T32" training grant, to be funded over the next five years by the National Institute for Allergy and Infectious Diseases, will allow Vincent Bonagura, MD, chief of pediatric immunology at SCH and a researcher at the Feinstein Institute, to train physicians to understand the basic immunobiology of the immune system and how it is involved in causing or preventing a myriad of diseases.
   
"This T32 grant, the first ever received by the North Shore-LIJ Health System, is significant because it's a national recognition of the major clinical and research expertise that Schneider Children's Hospital and the Feinstein Institute have in the area of immunology," said Arthur Klein, MD, senior vice president of children's services for the North Shore-LIJ Health System, and the executive director and chief of staff at SCH.
   
Physician/scientists selected for the new program will be able to spend time in any of the Feinstein Institute's various immunology labs. "They will have access to pediatric and adult patients who receive care for immunology-related diseases at Schneider Children's Hospital, North Shore University Hospital and LIJ Medical Center, along with patients cared for in other subspecialties that are related by the common language of immunology," said Dr. Bonagura. He added that there are an increasing number of immune-related disciplines -- including allergy, rheumatology, infectious diseases, cancers and autoimmune diseases -- that are in need of physicians and scientists trained in basic-science immunology who can expand our knowledge of the immune pathogenesis of these diseases, and provide novel and more effective therapies to treat patients.
   
"We need to train true academic doctors who will be able to advance the field," said Dr. Bonagura. The physician/scientist can also extend their training by applying for a fourth year within the Elmezzi Graduate School of Molecular Medicine (www.elmezzigraduateschool.org). The graduate school, part of the Feinstein Institute and the North Shore-LIJ Health System, trains physicians interested in becoming scientists as well. At the end of three years of training in the immunology physician/scientist program, students can earn a PhD degree in molecular medicine by completing a fourth year in the program.

Candidates for the immunology physician scientist training program will be drawn from a yearly complement of more than 110 pediatricians and internists applying for fellowship training in Allergy and Immunology Residency Training Program at Schneider Children's Hospital and LIJ Medical Center.
   
In addition to being chief of the Division of Allergy and Immunology at Schneider Children's Hospital, Dr. Bonagura is associate chair of pediatrics at SCH, and is currently a director of the American Board of Allergy and Immunology and Member of the American Board of Pediatrics. Betty Diamond, MD, director of the Feinstein's Center for Autoimmune and Musculoskeletal Diseases will be the co-director of the T32 Immunology Physician Scientist program. Dr. Diamond is an expert on rheumatic diseases, and focuses her attention on the brain problems associated with lupus.
   
The federal training grant fits with the mission of the Feinstein to discover and understand the causes and underlying mechanisms of human diseases, and to rapidly translate this information into diagnostic and therapeutic solutions for patients. Dr. Bonagura's lab focuses on human host defense mechanisms made against human papillomaviruses.

Contact
Jamie Talan
Science writer-in-residence
516-562-1232 (w) or 631-682-8781 (c)

###

Read the full story at http://www.prweb.com/releases/Feinstein_Institute/Allergy_Immunology/prweb2772464.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. MDMA Names New Director of Federal Affairs
2. Federal research plan to determine nanotech risks fails to deliver
3. Federal Employee Program Maintains Low Health Premiums In 2008
4. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
5. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
6. ACM Helps Medicaid Programs Comply With Federal Deficit Reduction Act Mandates
7. Boise(R) BEWARE(TM) Meets New Federal Guidelines Set Forth by Medicaid
8. HIV/AIDS Cases Among State and Federal Prison Inmates Fell for the Sixth Straight Year During 2005
9. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
10. Federal Trade Commission Attempts To Suppress Best-Selling Authors First Amendment Rights
11. CPF Urges Congress to Increase Funding for IPF Research in 2009 Federal Budget
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Federal Training Grant to Teach Doctors/Scientists Immunology
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... 2016  Collagen Matrix, Inc., ("Collagen Matrix") the ... of collagen and mineral based medical devices for ... Bill Messer has joined the company as ... the growing portfolio of oral surgery, neurosurgery, orthopaedic ... joins the Collagen Matrix executive team as an ...
Breaking Medicine Technology: